This bill requires owners and operators of designated publicly accessible premises to make naloxone kits available, keep them operational and ensure people on-site receive prescribed training. It also creates a registrar and a registration regime for kits, plus an inspector and enforcement framework governed by regulations.
The measure aims to normalize bystander access to naloxone across public settings and to create an administrative backbone — signage, maintenance standards, training requirements and a registry — so public-health officials and communities can better locate and maintain life-saving supplies. The scope and day-to-day obligations are left largely to regulations, so compliance costs and operational details will depend on regulatory design.
At a Glance
What It Does
The Act imposes duties on owners/operators of designated premises to install, maintain, test, signpost and make naloxone kits available and to ensure prescribed training for certain onsite persons. It requires registration of kits with a provincial registrar and gives inspectors powers to check compliance.
Who It Affects
Owners and operators of publicly accessible premises that are designated under the Act, the provincial registrar and Ministry that administers the regime, inspectors appointed under the Act, and first responders and bystanders who will rely on public naloxone deployment. Regulators will define additional affected locations and training providers.
Why It Matters
It shifts naloxone access from an ad hoc, voluntary model to a regulated public-access model with oversight and data collection. For compliance officers and facility managers, the bill creates predictable obligations; for public-health planners it creates a potential data source on kit locations and availability.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The Act creates a framework that moves naloxone from an informal harm-reduction tool toward a regulated public-access resource. It defines a class of "designated premises" whose owners or operators must ensure naloxone kits are present, accessible and maintained according to rules that the government will set out in regulations.
The regulations will fill in technical details such as exact placement, signage, maintenance schedules and who qualifies as a prescribed person for training.
To build an administrative record, the Act establishes a registrar (designated by the Minister) who will hold a registry of installed naloxone kits; the registrar also has to notify prescribed persons about registrations or changes. The Act expects owners/operators to interact with that registry and to inform it when kits are moved or removed, with the regulations governing timing and format of those notifications.For enforcement the Minister may appoint inspectors who can enter non-residential premises at reasonable times and inspect for compliance; the Act equips inspectors to examine documents and require production of relevant materials.
The Act also creates offences for failing to follow its requirements and for obstructing or misleading inspectors; corporate liability provisions reach officers and directors who authorize non-compliance.Most operational details are delegated to the Lieutenant Governor in Council: the regulations will designate additional classes of public premises, define registration processes, establish precise maintenance and training rules, and set fine amounts. The Act comes into force on a fixed delay after royal assent to give regulated parties and the government time to prepare for implementation.
The Five Things You Need to Know
The Act requires registration of each naloxone kit with the provincial registrar within 30 days after installation (or within 30 days of the Act coming into force if the kit is already installed).
Designated premises expressly include locations where a defibrillator is required by law or is voluntarily installed, and the regulations may add other publicly accessible premises.
Inspectors may enter any non-dwelling designated premises without a warrant and without prior notice at a reasonable time to inspect for compliance and may examine, copy or temporarily remove relevant documents.
The Act creates offences for contraventions, obstructing or misleading inspectors, and exposes corporations and their officers or directors to prescribed fines on conviction.
The Act comes into force six months after receiving Royal Assent, giving a fixed implementation period before obligations begin.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Policy rationale and context
The Preamble explains the public-health driver: opioid toxicity deaths and the high ratio of non-fatal overdoses where naloxone can help. It frames the Act as a preventive measure focused on public access, which signals the Legislature intends the measure to be proactive — not only to regulate workplaces but to extend access across public spaces.
Registrar designation
The Minister may designate a registrar who will operate the provincial registry of naloxone kits. Practically, this concentrates administrative responsibility in a ministry office or agency; the choice of registrar will determine IT, privacy, reporting and notification systems and how registrants interact with the government (online portal, forms, data retention).
What counts as a designated premises
This section sets the initial scope: premises where a defibrillator is required by law and places that voluntarily install a defibrillator, plus other public sites the regulations add. That approach uses an existing safety-equipment footprint (AED locations) as the starting universe and leaves the government to expand it administratively, which means the real scope of obligations will be set in regulations rather than the Act itself.
Operational duties and registration obligation
Owners/operators must install kits as regulations require, make them easily accessible, signpost their location, maintain and test them per manufacturer and prescribed guidelines, and ensure prescribed persons receive training. They must also register kits with the registrar within the statutory timeline and notify the registrar if kits are moved or removed. These coupled duties create a compliance workflow: procurement, placement, training, registry entry and ongoing maintenance.
Registrar notifications and enforcement architecture
The registrar must notify prescribed persons when kits are registered or moved/removed; this creates an information flow intended to alert public-health bodies or first responders to kit locations. Inspectors appointed by the Minister have broad powers to inspect non-dwelling premises without prior notice, examine and copy documents, and demand production — enforcement is administrative and evidence-gathering focused.
Offences and corporate liability
The Act creates criminal-style offences for non-compliance, obstruction and false statements, but leaves specific fines to the regulations. It extends liability to corporations and to officers or directors who authorize breaches. That structure allows penalties to be calibrated later but also signals that the regime contemplates meaningful consequences for systemic non-compliance.
Regulatory delegation and scope of rulemaking
Regulations can do heavy lifting: naming additional classes of premises, detailing registration procedures, prescribing maintenance, training and signage standards, and governing inspectors' processes and evidentiary rules. Because so many operational items are delegated, most compliance obligations will be determined by secondary legislation rather than text in the Act.
Delayed commencement
The Act sets a six-month delay from Royal Assent to coming into force. That delay is intended to give the government time to make regulations, set up a registrar and give owners/operators time to source kits, signage and training. It also creates a predictable compliance start date.
This bill is one of many.
Codify tracks hundreds of bills on this topic across all five countries.
Explore this topic in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- People at risk of opioid overdose and bystanders — easier access to naloxone in public places increases chances of timely reversal and survival.
- Public-health agencies and first responders — the registry and mandatory signage create better situational awareness and data for prevention planning and targeted distribution.
- Premises already equipping AEDs — owners who already maintain emergency equipment can integrate naloxone into existing safety programs and signage, capturing economies of scale.
- Communities with frequent public overdoses — formalized access and training can reduce response times and improve outcomes in high-incidence areas.
Who Bears the Cost
- Owners and operators of designated premises — they must buy, install, signpost, maintain, test and register kits and ensure prescribed training, which imposes purchase, labour and recordkeeping costs.
- Small businesses and non-profit organizations — if regulations designate broad categories of public spaces, small operators may face disproportionate compliance burdens and recurring maintenance obligations.
- The provincial government and Ministry administering the registrar — staffing, IT systems for a registry, inspector recruitment and training will require budget and operational resources.
- Corporate officers and directors — the extension of liability means senior management must ensure corporate compliance or risk fines, increasing governance and legal oversight costs.
Key Issues
The Core Tension
The central dilemma is between maximizing easy, rapid public access to a life-saving drug and imposing a regulatory compliance regime that shifts costs, administrative burden and potential liability onto owners/operators — a trade-off between public-health benefits and operational feasibility for the places expected to host kits.
The Act deliberately leaves key design choices to regulation: which public premises are covered, the exact form and timing of registration, the particulars of training, and the quantum of fines. That delegation accelerates passage but creates uncertainty for regulated parties who must wait for secondary rules to know precise obligations and costs.
The success of the scheme depends heavily on regulatory clarity, accessible registry technology and realistic maintenance standards tied to supply-chain realities for naloxone products.
The bill also creates several implementation tensions. A public registry and notification system improves response coordination but raises questions about data governance, the level of location detail published and who can access the information.
Requiring owners to register and maintain kits may improve availability but risks creating a compliance burden that discourages voluntary placements if costs or liabilities are perceived as too high. Enforcement via inspectors and prescribed fines gives teeth to the regime but will require funding and a compliance strategy that prioritizes public-health outcomes over punitive measures.
There's more to this law than the bill.
Codify Laws traces every connection across the legislative lifecycle.